z-logo
Premium
Medical utilization by immunodeficient, hemophiliac, and HIV positive children during summer camp: Evidence for a safe camper experience
Author(s) -
Bergman Jonathan,
Kinsella Eimear,
Kenny Janna,
Barbor Peter,
Zeltzer Paul
Publication year - 2005
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.20381
Subject(s) - medicine , psychosocial , pediatrics , population , human immunodeficiency virus (hiv) , disease , summer camp , family medicine , psychiatry , environmental health , psychology , developmental psychology
Background Continuation of normal activities is vital to psychosocial development of children with serious illnesses. The purpose of this study was to determine whether or not it was safe for HIV‐positive children and children with other immunodeficiencies to attend camp. Procedure The study population consisted of HIV (+) children, HIV negative siblings, and other immunodeficient campers attending Barretstown Gang (BG) Camp between 1998 and 2002. Their visit frequency to the on‐site medical facility was compared within the study population and between 2,323 contemporaneous campers with cancer. Results Over half of the HIV (+) children were on active therapy. Greater than 97% of staff (49/51) made at least one visit compared with 64% (149/233) of campers ( P  < 0.04). HIV (−) siblings had almost the same need for medical attention (total visits) as children with immunodeficiencies ( P  = 0.34). Most visits [88%] among all diagnostic groups except hemophilia were non‐disease related (328 vs. 47). Apart from URIs, there were few other infections and no fevers in the HIV(+) or immunodeficiency group, nor were there significant bleeds in the hemophiliacs. Most visits were for routine camp‐type ailments. Conclusions Our findings suggest that it is safe for HIV (+) and immunodeficient children to attend a properly staffed camp. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here